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AbsTrACT
Objective increasing numbers of outbreaks 
caused by contaminated duodenoscopes used for 
endoscopic retrograde cholangiopancreatography 
(ercP) procedures have been reported, some with 
fatal outcomes. We conducted a nationwide cross-
sectional study to determine the prevalence of bacterial 
contamination of reprocessed duodenoscopes in the 
netherlands.
Design all 73 Dutch ercP centres were invited to 
sample ≥2 duodenoscopes using centrally distributed 
kits according to uniform sampling methods, explained 
by video instructions. Depending on duodenoscope type, 
four to six sites were sampled and centrally cultured. 
contamination was defined as (1) any microorganism 
with ≥20 colony forming units (cFU)/20 ml (aM20) and 
(2) presence of microorganisms with gastrointestinal or 
oral origin, independent of cFU count (MgO).
results Sixty-seven out of 73 centres (92%) sampled 
745 sites of 155 duodenoscopes. ten different 
duodenoscope types from three distinct manufacturers 
were sampled including 69 (46%) Olympus tJF-
Q180V, 43 (29%) Olympus tJF-160Vr, 11 (7%) Pentax 
eD34-i10t, 8 (5%) Pentax eD-3490tK and 5 (3%) 
Fujifilm eD-530Xt8. thirty-three (22%) duodenoscopes 
from 26 (39%) centres were contaminated (aM20). 
On 23 (15%) duodenoscopes MgO were detected, 
including Enterobacter cloacae, Escherichia coli, 
Klebsiella pneumonia and yeasts. For both definitions, 
contamination was not duodenoscope type dependent (p 
values: 0.20 and higher).
Conclusion in 39% of all Dutch ercP centres, at least 
one aM20-contaminated patient-ready duodenoscope 
was identified. Fifteen per cent of the duodenoscopes 
harboured MgO, indicating residual organic material of 
previous patients, that is, failing of disinfection. these 
results suggest that the present reprocessing and process 
control procedures are not adequate and safe.
InTrODuCTIOn
Very recently, an increasing number of infectious 
outbreaks involving multidrug-resistant organisms 
(MDRO) caused by contaminated duodenoscopes, 
used for Endoscopic Retrograde Cholangiopancrea-
tography (ERCP) procedures, have been reported in 
both Europe and USA.1–5 These include outbreaks of 
infections with carbapenem-resistant Enterobacteri-
aceae, such as Escherichia coli and Klebsiella pneu-
moniae,3 4 of which some have been associated with 
fatal outcomes.6 Post-ERCP infections typically range 
between 2% and 4%.7 It is not clear to what extent 
these infections are caused by the procedure itself (ie, 
endogenous infections) or to what extent contami-
nated duodenoscopes are the source of infection (ie, 
exogenous infections). For example, in one specific 
outbreak with a persistently contaminated duodenos-
cope, 14.4% of all patients who underwent an ERCP 
significance of this study
What is already known on this subject?
 ► In the light of current outbreaks of multidrug-
resistant organisms caused by contaminated 
duodenoscopes, understanding to what extent 
duodenoscopes are inadequately reprocessed is 
crucial. Despite current reprocessing procedures, 
contamination of duodenoscopes continues to 
occur on a large scale worldwide.
 ► Several studies assessed contamination 
of duodenoscopes with varying outcomes. 
However, it is unclear what the true burden on 
a national level is.
What are the new findings?
 ► This cross-sectional study showed high 
prevalence rates of duodenoscope 
contamination in Endoscopic Retrograde 
Cholangiopancreatography (ERCP) centres in 
the Netherlands.
 ► In a substantial proportion of the cultured 
duodenoscopes, organic material of previous 
patients was still present, as they were 
contaminated with microorganisms of 
gastrointestinal or oral origin. These results 
suggest that the current combination of 
reprocessing and process control does not 
suffice.
 ► In this study, contamination occurred with all 
types of duodenoscopes, independent of type 
specific design.
How might it impact on clinical practice in the 
foreseeable future?
 ► Patients undergoing ERCP procedures remain to 
be at risk of being treated with contaminated 
equipment.
 ► Efficient surveillance strategies and 
reprocessing control measures are required 
to reduce the number of contaminated 
duodenoscopes, minimising the chance of 
interpatient transmission of microorganisms.
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were found to be colonised or infected.8 Outbreaks can be traced 
by bacterial typing. Especially when MDRO strains are involved, 
detection is easier as laboratories usually store these resistant 
strains and (retrospective) typing can be performed. This raises the 
question whether outbreaks with duodenoscopes are a new and 
emerging problem or whether outbreaks are only detected more 
frequently because of increased awareness facilitated by recognis-
able MDRO in patients.3 9 
During procedures in the gastrointestinal tract, all flexible 
endoscopes including duodenoscopes become heavily exposed 
to gastrointestinal flora.10 Therefore, flexible endoscopes are 
reprocessed after each procedure: a multistep process involving 
flushing, manual cleaning, automated cleaning, high-level disin-
fection and drying. Duodenoscopes are more difficult to repro-
cess compared with other flexible endoscopes.10 This is due to 
their complex design, which includes a side viewing tip, forceps 
elevator and elevator channel. Patient-ready duodenoscopes 
can be contaminated because of breaches in the reprocessing 
protocol, inadequate handling or because the current technique 
of reprocessing may be inadequate for the currently available 
duodenoscope design.11 Recent outbreaks have been docu-
mented to occur even when manufacturers’ Instructions For Use 
(IFU) for reprocessing were followed to the letter.2 3 9
In the Netherlands, as in many other parts of the world, 
process control is used. This means that reprocessing is consid-
ered to be adequate when it is performed according to the IFU 
and according to the standard handbook of the Dutch Steering 
Group for Flexible Endoscope Cleaning and Disinfection 
(SFERD).12 This handbook is based on regulations applicable in 
the Netherlands as well as the guidelines of the European Society 
of Gastrointestinal Endoscopy (ESGE).13 Despite international 
outbreaks and outbreaks in Dutch ERCP centres,14 15 both the 
IFU and SFERD do not include microbial surveillance after disin-
fection as a routine practice. Recently, contamination of duode-
noscopes has been assessed in several studies.16–18 Most studies 
were performed in a single university centre,16 18 making it diffi-
cult to extrapolate their results and estimate the true burden on 
a national level. A study among 21 centres was conducted by 
Brandabur et al,17 showing contamination rates with a wide vari-
ability across centres. To date, no such study has been conducted 
in a nationwide setting using a uniform sampling and culture 
method as well as examining all possible contamination sites.
Given the increase in the number of publications pertaining 
duodenoscope contamination and the potentially severe conse-
quences for patients, there is an urgency to develop a more 
thorough understanding of the scale of the problem. Therefore, 
the aim of this study was to determine the prevalence of micro-
bial contamination of patient-ready duodenoscopes in all ERCP 
centres in the Netherlands.
MATErIAls AnD METHODs
setting
We conducted a prospective nationwide cross-sectional study 
among all Dutch ERCP centres. In the Netherlands, over 16.000 
ERCP procedures are performed in 73 ERCP centres yearly.19 
All 73 Dutch ERCP centres were asked to sample at least two 
duodenoscopes at their own choosing and, if present, to include 
the newest Olympus TJF-Q180V (Olympus, Zoeterwoude, The 
Netherlands). Duodenoscopes were eligible for sampling if they 
were reprocessed and ready for patient use, for example, after 
high level disinfection or after drying in the storage cabinet. No 
data were recorded about the moment of sampling, surveillance 
methods or adherence to reprocessing or sampling protocols. No 
patient data were included in this study; therefore, there was no 
need for approval by the Medical Ethical Research Committee.
sample collection
Sampling was performed independently by local staff of the 
included ERCP centres, using a centrally distributed sample 
collection kit, according to a strict and uniform sampling protocol 
(see online supplementary files). This method was developed by 
a multidisciplinary team of reprocessing staff, medical device 
experts, infection control professionals, medical microbiologists 
and gastroenterologists based on the SFERD standard hand-
book.12 The sampling protocol was explained using 12 instruc-
tion videos available online (see online supplementary videos). 
As examples, the sampling and labelling procedure was shown 
in detail using one Olympus TJF-160VR and one Pentax ED34-
i10T (Pentax, Dodewaard, The Netherlands) duodenoscope. 
Duodenoscopes were sampled while placed in the Automated 
Endoscope Reprocessor or on a sterile surface. Depending on 
the duodenoscopes type, four to six sites were sampled. The 
four sites present in all duodenoscope types were: (1) a flush 
of the biopsy channel, (2) a flush of the suction channel, (3) a 
swab from the forceps elevator and (4) a single brush through 
the biopsy and suction channel. Type-dependent samples were: 
(1) a swab of the removable protection cap and (2) a flush of 
the elevator channel or air/water channel, if these channels were 
unsealed. Channels were flushed with sterile physiological saline 
solution of which at least 20 mL was collected at the distal tip 
in a sterile container. The flush fluid was aspirated with a sterile 
needle and injected in two 9.5 mL BD Vacutainers without addi-
tives (Becton Dickinson, Etten-Leur, The Netherlands). Forceps 
elevator and protection cap were sampled with ESwabs (Copan 
Italia S.p.A., Brescia, Italy). Type dependent, Olympus BW-412T 
or Pentax CS6021T single-use endoscope cleaning brushes were 
used to brush the biopsy and suction channel. Both ESwabs and 
the brush tip were transported in ESwab medium. Instructions 
were to swab first, second to flush the channels and finally to 
brush the channels. The decision to reprocess the endoscope 
after sampling was up to the respective centres and was not 
documented for the purpose of the current study. Samples were 
sent to the Erasmus MC department of Medical Microbiology 
and Infectious Diseases for culturing.
Culturing and interpretation
Samples were cultured on the day of receipt. Channel flushes 
were filtrated over a 0.45 µm filter of which the filtrate was 
forced on R2A agar. ESwabs and brush tips were vortexed in 
their ESwab medium of which 0.75 mL was poured on a blood 
agar. Samples were incubated at 35°C, examined for growth for 
72 hours and read at 24 hours, 48 hours and 72 hours. Culture 
results were presented in colony forming units (CFU)/20 mL 
per microorganism. Results were sent to the respective ERCP 
centres without further interpretation: further action was up 
to the respective ERCP centre and was not documented for 
the purpose of the current study. At the time of study conduct, 
Dutch guidelines for endoscopy centres stated that in case 
of contamination with a subset of indicator microorganisms 
with ≥20 CFU/20 mL or in case of persistent contamina-
tion, endoscopes should be quarantined and possible causes 
be investigated.12 Cultured microorganisms were categorised 
depending on their origin into gastrointestinal, oral, skin and 
waterborne flora. Contamination was defined according to 
two definitions: (1) microbial growth with ≥20 CFU/20 mL 
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guideline and Dutch SFERD handbook12 13 or (2) presence of 
microbial growth (≥1 CFU/20 mL) of gastrointestinal and/or 
oral microorganisms (MGO).
statistical analysis
Categorical data are presented in percentages. Mean (range) and 
median (IQR) are given for continuous and skewed data, respec-
tively. The χ² test was used to compare categorical data and 
Student’s t-test or Mann Whitney U-test was used to compare 
continuous data. Contamination rates of duodenoscope types 
and sample sites were compared according to a logistic regres-
sion model, using the SAS procedure GENMOD. This model 
adjusted for the multiple samples of each unique duodenoscope, 
with each duodenoscope clustered within their respective ERCP 
centre. Duodenoscope types were compared with the newest 
Olympus TJF-Q180V type as a reference and sample sites were 
compared with the flush of the biopsy channel. For both anal-
yses, duodenoscope types or sample sites could be included if 
there was at least one contamination case and one non-contam-
ination case. Analyses were performed using SAS V.9.4 (SAS, 
Cary, North Carolina, USA) and SPSS V.21.0 (IBM, Armonk, 
New York, USA).
rEsulTs
Between June 2015 and March 2016, 67 out of 73 (92%) Dutch 
ERCP centres sampled 745 sites of 155 endoscopes. Five endo-
scopes were excluded: four duodenoscopes from one centre 
whose samples were cultured in their own microbiology depart-
ment and one gastroscope from another centre as this type of 
endoscope does not have a forceps elevator, that is, no duode-
noscope (figure 1). Twenty-six samples from 17 duodenoscopes 
were excluded, as these sites did not correspond with the spec-
ified duodenoscope type. This resulted in an inclusion of 150 
duodenoscopes with a total of 701 samples from 66 (92% of all 
centres) ERCP centres (figure 1). The median time between local 
sampling and culturing in the Erasmus MC was 1 day (IQR 1–2). 
Table 1 provides an overview of the contamination prevalence 
per duodenoscope type and sample site for AM20 and MGO 
contamination definitions. Contamination according to the 
AM20 definition was found in 33 (22%) out of the 150 repro-
cessed and patient-ready duodenoscopes. Duodenoscopes were 
most often contaminated with skin flora (n=17; 11%) and to 
a lesser extent with waterborne flora (n=12; 8%), gastrointes-
tinal flora (n=10; 7%) or oral flora (n=4; 3%). Contamination 
according to the MGO definition was found in 23 (15%) duode-
noscopes. Table 2 shows all different microorganisms that were 
cultured, among others Escherichia coli, Klebsiella pneumoniae 
and Pseudomonas aeruginosa.
Ten different duodenoscope types from three distinct manu-
facturers (ie, Olympus, Pentax and Fujifilm) were sampled. 
Contamination as defined by AM20 was identified in five 
different duodenoscope types and contamination as defined by 
MGO was identified in four different types. As shown in figure 2, 
contamination for AM20 (four duodenoscope types included) as 
well as MGO (two duodenoscope types included) was shown not 
to be type-dependent (all p>0.05).
The AM20 contaminated duodenoscopes originated from 26 
(39%) centres across the Netherlands. No difference (p=0.10) 
was shown in contamination prevalence between academic 
tertiary medical centres (n=3/8; 38%), specialised peripheral 
medical centres (n=13/23; 57%) or general peripheral medical 
centres (n=10/35; 29%). This was also the case for MGO-con-
taminated duodenoscopes originating from 19 (28%) centres. 
No difference was found (p=0.25) between academic tertiary 
medical centres (n=3/8; 38%), specialised peripheral medical 
centres (n=9/23; 39%) and general peripheral medical centres 
(n=7/35; 20%).
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Microorganisms were cultured from 166 (24%) sample sites 
of 97 (65%) duodenoscopes. Additionally, 54 (8%) sample 
sites of 41 (27%) duodenoscopes contained two or more 
microorganisms, in some cases up to five different microorgan-
isms. As shown in table 1, all sample sites, except the flush of 
the elevator channel, were found positive for AM20 or MGO 
Table 1 Prevalence of AM20 and MGO contamination for duodenoscopes and sample sites
Duodenoscope type n
AM20 MGO
Contam. not contam. Contam. not contam.
  All duodenoscopes 150 33 (22%) 117 (78%) 23 (15%) 127 (85%)
  Olympus TJF-Q180V 69 15 (22%) 54 (78%) 15 (22%) 54 (78%)
  Olympus TJF-160VR 43 13 (30%) 30 (70%) 6 (14%) 37 (86%)
  Olympus TJF-160R 8 1 (13%) 7 (87%) 0 8
  Olympus TJF-140R 2 0 2 0 2
  Olympus TJF-145 2 0 2 0 2
  Pentax ED34-i10T 11 3 (27%) 8 (73%) 0 11
  Pentax ED-3490TK 8 0 8 0 8
  Pentax ED-3680TK 1 0 1 1 (100%) 0
  Fujifilm ED-530XT8 5 0 5 0 5
  Fujifilm ED-530XT 1 1 (100%) 0 1 (100%) 0
sample site
AM20 MGO
Contam. not contam. Contam. not contam.
  All sample sites 701* 47 (7%) 654 (93%) 35 (5%) 666 (95%)
  Biopsy channel 146 5 (3%) 141 (97%) 6 (4%) 140 (96%)
  Suction channel 137 4 (3%) 133 (97%) 5 (4%) 132 (96%)
  Forceps elevator 148 14 (10%) 134 (90%) 7 (5%) 141 (95%)
  Brush 139 17 (12%) 122 (89%) 14 (10%) 125 (90%)
  Protection cap 56 6 (11%) 50 (89%) 3 (5%) 53 (95%)
  Elevator channel 53 0 53 0 53
  Air/water channel 26 1 (5%) 21 (95%) 0 22
*Sampling of all possible sites would have yielded 745 samples: 44 (6%) sites were not sampled. This included 4/150 (3%) biopsy channel, 13/150 (9%) suction channel, 2/150 
(1%) forceps elevator, 11/150 (7%) brush, 9/65 (13%) protection cap, 2/55 (4%) elevator channel and 3/25 (12%) air/water channel samples.
AM20, microbial growth with ≥20 CFU/20 mL of any type of microorganism; Contam., contaminated; MGO, presence of any microbial growth of gastrointestinal or oral 
microorganisms; Not contam., not contaminated. 
Table 2 Cultured microorganisms of 150 duodenoscopes
Gastrointestinal flora independent of CFu count Oral flora independent of CFu count
no. of duodenoscopes Quantity range no. of duodenoscopes Quantity range
Yeasts 7 6–100 CFU Moraxella spp. 4 1 CFU
Klebsiella pneumoniae 4 100 - >100 CFU Streptococcus salivarius 4 1–15 CFU
Enterobacter cloacae 3 100 - >100 CFU Moraxella osloensis 3 1 CFU – 100 CFU
Escherichia coli 2 50 and 100 CFU Streptococcus mitis 2 30 and 50 CFU
Klebsiella oxytoca 2 100 CFU- >100  CFU Neisseria flavescens 1 1 CFU
Enterococcus faecium 1 1 CFU Rothia spp. 1 10–30 CFU
Enterococcus faecalis 1 100 Streptococcus mutans 1 2 CFU
Pseudomonas aeruginosa 1 100 CFU Streptococcus oralis 1 5 CFU
Staphylococcus aureus 1 >100 CFU Streptococcus spp. 1 10 CFU
skin flora ≥20 CFu Waterborne flora ≥20 CFu
no. of duodenoscopes Quantity range no. of duodenoscopes Quantity range
Bacillus spp. 5 40–100 CFU Stenotrophomonas maltophilia 3 100 - >100 CFU
Micrococcus luteus 5 100 CFU Acinetobacter spp. 2 80 and 100 CFU
Staphylococcus epidermidis 4 50–100 CFU Agrobacterium radiobacter 2 20 and 100 CFU
Kocuria spp. 2 25 and 100 CFU Paracoccus yeeii 2 30 and 100 CFU
Staphylococcus hominis 2 25 and 100 CFU Achromobacter xylosoxidans 1 100 CFU
Staphylococcus warneri 2 50 and 80 CFU Alternaria spp. 1 >100 CFU
Kocuria rhizophila 1 >100 CFU Pseudomonas monteilii 1 100 CFU
Micrococcus spp. 1 30 CFU Pseudomonas putida 1 100 CFU
Staphylococcus auricularis 1 >100 CFU Sphingomonas paucimobilis 1 100 CFU
Staphylococcus spp. (CNS) 1 60 CFU Rhizobium spp. or Sphingobium spp. 1 >100 CFU
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contamination. The flush of the biopsy channel was used as 
a reference to compare the contamination prevalence of all 
sample sites. Three sample sites had a higher probability of 
being contaminated (figure 3). According to the AM20 defini-
tion, the swab of the elevator (OR 2.93, 95% CI 1.13 to 7.61; 
p=0.03) and the swab of the protection cap (3.38, 95% CI 1.08 
to 10.55; p=0.04) were more often contaminated. The brush 
of the biopsy/suction channel was more often contaminated 
for both AM20 (OR 3.87, 95% CI 1.13 to 7.61; p=0.006) and 
MGO (OR 2.64, 95% CI 1.14 to 6.14; p=0.02) definitions.
DIsCussIOn
In our nationwide prevalence study, we found that over one-fifth 
of sampled duodenoscopes were contaminated according to 
AM20 definition, with 39% of Dutch ERCP centres having at 
least one contaminated duodenoscope intended to be ready for 
Figure 2 OR for each duodenoscope type on contamination. AM20, microbial growth with ≥20 CFU/20 mL of any type of microorganism; CFU, 
colony forming units; MGO, presence of any microbial growth of gastrointestinal or oral microorganisms.
Figure 3 OR for each sample site on contamination. AM20, microbial growth with ≥20 CFU/20 mL of any type of microorganism; CFU, colony 
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patient use. Furthermore, MGO were cultured on 15% of the 
sampled duodenoscopes, indicating the presence of organic 
residue of previously treated patients. Our observations coin-
cide with worldwide reported outbreaks indicating that exog-
enous transmission of bacteria and associated infections and 
even viral infections related to contaminated duodenoscopes 
continue to threaten patients undergoing ERCP.1–4 20 There-
fore, stringent measures are required to lower the number of 
contaminated duodenoscopes in order to minimise the risk 
of interpatient microbial transmission during ERCP and to 
prevent future outbreaks.
The prevalence of duodenoscope contamination in this 
study was in line with reports from several retrospective single 
tertiary centre studies.18 21 22 Recent studies by Brandabur et al 
and Ross et al performing postprocedure or everyday morning 
cultures reported remarkably lower contamination rates.16 17 
This could be explained by the fact that continuous feedback of 
microbial surveillance resulted in a raised alertness, resulting in 
lower contamination rates over time. In the centres included in 
the present study, it is not common practice to perform surveil-
lance cultures, especially no daily or postprocedure cultures, as 
Dutch guidelines do not demand these.12 23 Other contributing 
factors could be differences in sampling and culture methods. 
For example, we used a more sensitive contamination cut-off 
and a longer incubating time than Brandabur et al and Ross et 
al.16 17 The present study was conducted in 2015–2016 after 
multiple MDRO-outbreaks were reported (inter)nationally, 
including reports of outbreaks in Dutch ERCP centres as early 
as 2009 and 2012.14 15 Despite current national awareness 
about the potential consequences of contamination, our results 
were concordant with a cross-sectional multicentre (n=37) 
Canadian study published in 2002 in which a contamination 
prevalence of 30% was reported using a contamination cut-off 
of 10 CFU/mL.24
The most recent duodenoscope types introduced into the 
market have distinct design changes, including sealing of 
the elevator channel and a sealed protection cap, aimed at 
preventing contamination and the need for reprocessing at 
these locations. In 2012, an outbreak in our hospital was 
linked to the newest Olympus TJF-Q180V duodenoscope.2 
After the outbreak, the duodenoscope was investigated by 
Olympus and an independent expert. One of the conclusions 
was that TJF-Q180V’s specific design features hampered 
adequate cleaning and disinfection.15 To further investigate 
these matters, we asked participating centres to include the 
TJF-Q180V duodenoscope, if present. The current study 
shows that contamination for both AM20 and MGO were not 
restricted to certain duodenoscope types. This is in line with 
outbreaks that have been reported involving various duodeno-
scope types from all three manufacturers.6 Moreover, Brand-
abur et al also reported that culture positivity was not affected 
by scope type.17 Despite differences in design, none of the 
available duodenoscope types seem excluded from the risk of 
contamination.
The differences in the type of cultured flora can give an indi-
cation where in the reprocessing process the duodenoscopes 
were contaminated. Several guidelines that advocate active 
microbiological surveillance give guidance on how to interpret 
culture results.13 25 In this study, a substantial number of duode-
noscopes were contaminated with skin and waterborne flora. 
Contamination with skin flora is thought to arise from handling 
and therefore could potentially easily be reduced by improved 
handling during reprocessing and transport. However, the 
presence of skin flora could be due to contamination during 
sampling. We cannot rule out this cause as sampling on site was 
not audited. Dutch centres have to use filtered water for repro-
cessing facilities and process control involves quarterly micro-
biological control of the rinse water.12 In our view, persistent 
contamination with waterborne flora demands a thorough 
investigation as it can be caused by several factors, including 
contamination of the water supply, inadequate filtering of the 
water supply and inadequate drying of the endoscope during 
storage. Contamination with MGO indicates inadequate repro-
cessing as originating from the gastrointestinal tract. This type 
of contamination could be due to a breach in the reprocessing 
procedure or because the reprocessing procedure cannot be 
adequately performed due to reprocessing, endoscopic or 
procedure specific risk factors. Currently, we are working on 
a Dutch guideline in which actions following positive cultures 
will be described extensively. The guideline will be submitted 
for international publication in the near future. Differences 
in Automated Endoscope Reprocessors, endoscope hang time 
and different reprocessing methods do not seem to affect 
contamination rates.17 26 27 Beside the complex design of the 
duodenoscope,2 6 28 endoscope age has also been suggested as 
a risk factor,2 18 26 with Brandabur et al proposing the number 
of procedures as a better indicator for endoscope usage.17 
Contamination does not seem to be confined to duodenos-
copes: single-centre studies show that coloscopes and gastro-
scopes can have similar contamination rates.18 22 However, 
compared with duodenoscopes, other gastrointestinal endo-
scopes are far less the reason of recent reported outbreaks.5 We 
hypothesise that this could be due to differences between types 
of procedures as ERCP procedures tend to be more invasive, 
entering sterile body cavities and could have a more compro-
mised patient population. The latter defines the more serious 
and therefore detectable clinical outcome of transmission of 
microorganisms by ERCP compared with other gastrointes-
tinal endoscopes.
In the present study, the brush, the forceps elevator and 
the protection cap had the highest probability of detection of 
contamination. The forceps elevator is a site known to be prone 
to persistent contamination.2 3 16 17 The brush is also noted as 
a site that can harbour the involved microorganism during an 
outbreak.16 Borescope channel inspections of gastroscopes and 
coloscopes performed by Ofstead et al revealed that all repro-
cessed endoscope channels contained fluid, discoloration and 
debris.29 This underlines that the biopsy channel is subject to 
heavy wear and tear: devices are introduced frequently, causing 
soiling of the channel which adds to the risk of contamina-
tion.30 Remarkably, in the present study, the elevator channel 
was not contaminated in any duodenoscope and the air/water 
channel in only one duodenoscope. Sampling of these specific 
channels is often not performed during surveillance and often 
not even in the case of an outbreak.16
In current guidelines and studies, there is no international 
consensus on a uniform sampling and culturing method, 
although several differences could potentially affect culture 
outcomes. The location and the number of sample sites differ 
greatly: in some instances, a channel brush18 31 or swab of the 
forceps elevator12 24 is omitted. When the channel brush or the 
forceps elevator would not be cultured in the present series, 
19% (6/32) or 9% (3/32), respectively, of the AM20 contam-
inated duodenoscopes would have been missed. Some studies 
and guidelines advocate a different order of sampling, such 
as retrograde sampling or the flush-brush-flush method, as it 
might have a higher sensitivity.14 25 31 32 The cleaning brush that 
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subsequent samples. However, in this study, the brush sample 
was performed last. A sample flush with a neutraliser instead of 
saline solution can prevent false negative outcomes due to the 
biocidal activity of residual disinfectants33 34 and is advocated 
by the French guideline and several French studies.18 21 33 35 
The toxicity of the neutralisers might also cause false nega-
tives,36 and theoretically the endoscope should not contain 
any residual disinfectant after a successful reprocessing cycle. 
Other guidelines including the Dutch guideline, according to 
which our sampling protocol was designed, do not require 
a neutraliser based on current evidence.12 13 25 31 However, 
if a neutraliser effectively prevents false negative outcomes, 
the contamination rates in this study could be even higher. A 
longer incubation time is associated with a higher culture posi-
tivity rate. Saliou et al state that endoscope samples should be 
incubated for at least 1 week. In their study, after 48 hours only 
55.5% of the final number of contaminated endoscopes were 
found positive.18 Some studies and guidelines use an incuba-
tion time of 48 hours.16 17 25 31 In this study, we have chosen 
for a 72 hours period: the microorganisms of concern would 
be detected and the study results could by compared with the 
centres’ previous microbiological surveillance results. Also, the 
choice of growing media for incubation of flush samples can 
affect the culture positivity rate. R2A agar, as used in this study, 
has a high sensitivity, especially for slower growing microor-
ganisms.37 38 To be able to compare test results and omit false 
negative test results, standardised and uniform instructions for 
sampling, culturing and interpretation of culture results should 
be devised which, based on results in this study, should include 
a channel brush and a swab of the forceps elevator as these 
sites pose the highest risk of contamination.
To the best of our best knowledge, this is the first study 
assessing contamination of duodenoscopes nationwide. 
Another strength of our study is that we cultured all samples 
in one microbiology laboratory using a standardised protocol. 
Finally, because of the extensive sampling method we were 
able to analyse all possible contamination sites. This study has 
some limitations. This study could only be conducted nation-
wide as a cross-sectional study without follow-up samples 
of the duodenoscopes: improvement of contamination rates 
or persistent contamination was not assessed. Furthermore, 
sampling was conducted independently by local staff. Although 
we provided strict sampling protocols with clear video instruc-
tions on how the culture procedure should be performed, we 
were not able to check for adherence to the sampling protocol. 
Also the conditions in which the endoscopes were sampled (ie, 
just disinfected or after drying with or without alcohol flush or 
positive air flow) were not recorded. Potential differences in 
culture outcomes between sampling post-disinfection or post-
drying, differences in drying times or other storage or repro-
cessing parameters could not be assessed. However, all assessed 
duodenoscopes were ready for use in patients and should not 
be contaminated, regardless of the moment of reprocessing. 
We hypothesise that the effect of these factors on the presence 
of especially gastrointestinal and or oral flora is rather small, as 
we see this as a failure of the reprocessing process. Last, a small 
amount of sites were not sampled, which could cause underes-
timation of the total number of contaminated duodenoscopes.
The observed nationwide high prevalence of contamination 
of patient-ready duodenoscopes is a clear indication that the 
current combination of reprocessing and process control is not 
sufficient. All participating hospitals are dedicated endoscopy 
centres following the national guideline that underlines process 
control. This includes reprocessing exactly according to the 
manufacturer’s instructions and extensive yearly audits.12 23 
As adherence to reprocessing protocols was not observed, this 
study shows real-life outcomes of patient-ready duodenos-
copes with little bias. Regardless of whether the precise cause 
of contamination was a breach in the reprocessing process 
or the complex duodenoscope design, process control was 
not able to identify and prevent such large-scale inadequate 
reprocessing. This calls for concerted action by all parties 
involved, that is,: manufacturers, regulatory bodies, govern-
ment agencies, gastroenterologists and medical microbiolo-
gists. Nowadays, ERCP has evolved into a minimally invasive 
interventional procedure having replaced more invasive and 
complicated surgical procedures. It is an essential procedure 
practiced all over the world with over 650 000 procedures 
performed in USA annually.39 During revision of the market 
clearance of the Olympus TJF-Q180V duodenoscope, the U.S. 
Food and Drug Administration (FDA) stated that a decrease in 
ERCP capacity would be unacceptable.40 However, contami-
nated duodenoscopes put patients at risk of developing clin-
ically relevant infections by transmission of microorganisms.
In 2015, the FDA issued a warning that some parts of duode-
noscopes may be extremely difficult to access and adequate 
cleaning of all areas may not be possible.28 Since then addi-
tional measures have been suggested,11 including alterna-
tive reprocessing methods or implementation of microbial 
surveillance as proposed by Centres for Disease Control and 
Prevention.10 31 Eventually, radical changes in the design of 
duodenoscopes should ensure thorough cleaning and disinfec-
tion. However, development and market introduction of such 
newly designed duodenoscopes will require substantial time. 
A complicating factor is that standardised procedures to test 
duodenoscopes in their ability to be adequately cleaned and 
disinfected are not available. Therefore, on the short term, 
we should not solely rely on process control as there is no 
scientific proof that this serves as a reliable proxy for safe and 
clean duodenoscopes. Uniform guidelines and instructions for 
microbial surveillance should be developed. Also, an interna-
tional registry for contaminated scopes should be instituted in 
order to truly estimate the scale of the problem and track its 
impact and revolution over time.
To conclude, this nationwide cross-sectional study shows 
high prevalence rates of contamination of duodenoscopes in 
Dutch ERCP centres. The recent reports on infections due to 
contaminated endoscopes will probably be due to involvement 
and alertness on highly resistant microorganisms, but also the 
more and more complex designs of endoscopes can play a role 
in this emergence. Additional preventive measures including 
microbial surveillance strategies are needed to reduce the 
number of contaminated duodenoscopes.
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